| An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain J Kutzsche, GA Guzman, A Willuweit, O Kletke, E Wollert, I Gering, ... British journal of pharmacology 181 (12), 1734-1756, 2024 | | 2024 |
| Novel 4-nitroimidazole analogues: synthesis, in vitro biological evaluation, in silico studies, and molecular dynamics simulation YA Al-Soud, SO Al-Sawakhnah, RA Al-Qawasmeh, NA Al-Masoudi, ... Zeitschrift für Naturforschung C 79 (3-4), 61-71, 2024 | | 2024 |
| 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases B Michalska, M Dzięgielewski, J Godyń, T Werner, M Bajda, T Karcz, ... ACS Chemical Neuroscience 15 (6), 1206-1218, 2024 | | 2024 |
| Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease DE Hafez, M Dubiel, G La Spada, M Catto, D Reiner-Link, YT Syu, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2175821, 2023 | 13 | 2023 |
| N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer’s Disease T Hofmanova, C Marques, AT García-Sosa, Ó López, L Leitzbach, ... Results in Chemistry 6, 101032, 2023 | 2 | 2023 |
| Sodium channel blockers attenuate the progression of preclinical models of multiple sclerosis by inhibitions of CNS immune cell infiltration M Dietrich, M Sindi, T Muntefering, V Dobelmann, C Hecker, I Andrea, ... MULTIPLE SCLEROSIS JOURNAL 29, 607-608, 2023 | | 2023 |
| Thiazole derivatives as dual inhibitors of deoxyribonuclease I and 5-lipoxygenase: A promising scaffold for the development of neuroprotective drugs A Marković, A Živković, M Atanasova, I Doytchinova, B Hofmann, ... Chemico-Biological Interactions 381, 110542, 2023 | 6 | 2023 |
| Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain K Szczepańska, T Karcz, M Dichiara, S Mogilski, J Kalinowska-Tłuścik, ... Journal of Medicinal Chemistry 66 (14), 9658-9683, 2023 | 2 | 2023 |
| Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy J Alizadeh, SC da Silva Rosa, X Weng, J Jacobs, S Lorzadeh, A Ravandi, ... European Journal of Cell Biology, 151337, 2023 | 23 | 2023 |
| Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo A Olejarz-Maciej, S Mogilski, T Karcz, T Werner, K Kamińska, J Kupczyk, ... Molecules 28 (10), 4199, 2023 | | 2023 |
| Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect M Staszewski, M Iwan, T Werner, M Bajda, J Godyń, G Latacz, ... Pharmaceuticals 16 (5), 675, 2023 | 3 | 2023 |
| Histamine receptors in GtoPdb v. 2023.1 P Chazot, M Cowart, H Fukui, CR Ganellin, R Gutzmer, HL Haas, SJ Hill, ... IUPHAR/BPS Guide to Pharmacology CITE 2023 (1), 2023 | | 2023 |
| Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in mice Ö Uluckan, S Bruno, Y Wang, N Wack, J Wilzopolski, JF Goetschy, ... European Journal of Pharmacology 945, 175533, 2023 | 2 | 2023 |
| Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives D Łażewska, M Kaleta, P Zaręba, J Godyń, M Dubiel, ... Molecules 28 (5), 2349, 2023 | 3 | 2023 |
| Targeting UGCG overcomes resistance to lysosomal autophagy inhibition V Jain, SL Harper, AM Versace, D Fingerman, GS Brown, M Bhardwaj, ... Cancer discovery 13 (2), 454-473, 2023 | 8 | 2023 |
| Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation E Honkisz-Orzechowska, K Popiołek-Barczyk, Z Linart, J Filipek-Gorzała, ... Inflammation Research 72 (2), 181-194, 2023 | 3 | 2023 |
| Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors CMSQ Aranha, D Reiner-Link, LR Leitzbach, FB Lopes, H Stark, ... Bioorganic & Medicinal Chemistry 78, 117132, 2023 | 2 | 2023 |
| Discovery of a new activator of Slack potassium channels with robust efficacy in models of histamine-independent and chronic itch A Balzulat, WF Zhu, C Flauaus, V Hernandez-Olmos, J Heering, ... bioRxiv, 2023.10. 05.560997, 2023 | 1 | 2023 |
| Pharmacy Archives A Link, S Laufer, W Diederich, C Veale, A Artese, K Augustyns, ... ARCHIV DER PHARMAZIE 356 (1), 2023 | | 2023 |
| Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis K Griess, M Rieck, N Müller, G Karsai, S Hartwig, A Pelligra, R Hardt, ... Nature cell biology 25 (1), 20-29, 2023 | 12 | 2023 |
